NEW YORK, July 9, 2024 (GLOBE NEWSWIRE) — The Gross Law Firm issues the following notice to shareholders of Biogen Inc. (NASDAQ: BIIB).
Shareholders who purchased shares of BIIB during the specified period are encouraged to contact the firm regarding a possible appointment as lead plaintiff. Appointment as lead plaintiff is not required to participate in any recovery.
CONTACT US HERE:
SCHOOL LESSON: 3 February 2022 to 13 February 2024
ACCUSATIONS: The complaint alleges that during the Class Period, Defendants made materially false and/or misleading statements and/or failed to disclose that: (i) Biogen overstated its efforts to improve its transparency, corporate governance and compliance controls and procedures and the effectiveness of those controls and procedures; (ii) Biogen accordingly maintained inadequate compliance controls and procedures in connection with its foreign operations; (iii) Biogen and/or its employees engaged in unlawful or otherwise inappropriate conduct in several countries; (iv) the foregoing exposed the Company to an increased risk of governmental and/or regulatory scrutiny and enforcement actions, as well as significant legal, financial and reputational damages; (v) Biogen overstated the strength of its Alzheimer’s-related product portfolio, including its joint efforts and success with pharmaceutical company Eisai in launching and making Leqembi available; (vi) Biogen also downplayed the negative impact of the Reata acquisition on its non-GAAP diluted earnings per share in fiscal 2023; (vii) all of the foregoing would likely have a material adverse effect on Biogen’s 2023 results; and (viii) as a result, the Company’s public statements were materially false and misleading at all relevant times.
DEADLINE: 22 July 2024 Shareholders should not hesitate to sign up for this class action lawsuit. Register your information here: https://securitiesclasslaw.com/securities/biogen-loss-submission-form/?id=89664&from=3
NEXT STEPS FOR SHAREHOLDERS: Once you register as a shareholder who purchased shares of BIIB during the above-mentioned period, you will be enrolled in a portfolio monitoring software that will provide you with status updates throughout the lifecycle of the case. The deadline to apply to be lead plaintiff is July 22, 2024. There is no cost and no obligation to you to participate in this case.
WHY GROSS LAW FIRM? The Gross Law Firm is a nationally recognized class action litigation firm. Our mission is to protect the rights of all investors who have suffered from deception, fraud, and illegal business practices. The Gross Law Firm is committed to ensuring that companies adhere to responsible business practices and act as corporate citizens. The firm seeks compensation on behalf of investors who have suffered losses when a company’s false and/or misleading statements or omission of material information have resulted in the artificial inflating of the company’s stock price. Attorney Advertising. Past results do not guarantee similar results.
CONTACT:
The law firm Gross
15 West 38th Street, 12th floor
New York, NY, 10018
Email: [email protected]
Phone: (646) 453-8903
